Mandel JJ - Search Results

1

Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.

Hamza MA, Mandel JJ, Conrad CA, Gilbert MR, Yung WK, Puduvalli VK, DeGroot JF. Hamza MA, et al. Among authors: mandel jj. J Neurooncol. 2014 Aug;119(1):135-40. doi: 10.1007/s11060-014-1460-z. Epub 2014 May 7. J Neurooncol. 2014. PMID: 24803001 Free PMC article.

2

Update on anti-angiogenic treatment for malignant gliomas.

de Groot JF, Mandel JJ. de Groot JF, et al. Among authors: mandel jj. Curr Oncol Rep. 2014 Apr;16(4):380. doi: 10.1007/s11912-014-0380-6. Curr Oncol Rep. 2014. PMID: 24510742 Review.

3

Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.

Mandel JJ, Yust-Katz S, Cachia D, Wu J, Liu D, de Groot JF, Yung AW, Gilbert MR. Mandel JJ, et al. J Neurooncol. 2014 Dec;120(3):597-605. doi: 10.1007/s11060-014-1592-1. Epub 2014 Aug 29. J Neurooncol. 2014. PMID: 25168214

4

Venous thromboembolism (VTE) and glioblastoma.

Yust-Katz S, Mandel JJ, Wu J, Yuan Y, Webre C, Pawar TA, Lhadha HS, Gilbert MR, Armstrong TS. Yust-Katz S, et al. Among authors: mandel jj. J Neurooncol. 2015 Aug;124(1):87-94. doi: 10.1007/s11060-015-1805-2. Epub 2015 May 19. J Neurooncol. 2015. PMID: 25985958

5

Wound healing complications in brain tumor patients on Bevacizumab.

Ladha H, Pawar T, Gilbert MR, Mandel J, O-Brien B, Conrad C, Fields M, Hanna T, Loch C, Armstrong TS. Ladha H, et al. J Neurooncol. 2015 Sep;124(3):501-6. doi: 10.1007/s11060-015-1868-0. Epub 2015 Aug 23. J Neurooncol. 2015. PMID: 26298437

6

Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.

Cachia D, Kamiya-Matsuoka C, Mandel JJ, Olar A, Cykowski MD, Armstrong TS, Fuller GN, Gilbert MR, De Groot JF. Cachia D, et al. Among authors: mandel jj. J Neurooncol. 2015 Nov;125(2):401-10. doi: 10.1007/s11060-015-1930-y. Epub 2015 Sep 9. J Neurooncol. 2015. PMID: 26354773 Free PMC article.

7

Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.

Mandel JJ, Cachia D, Liu D, Wilson C, Aldape K, Fuller G, de Groot JF. Mandel JJ, et al. J Neurooncol. 2016 Aug;129(1):147-54. doi: 10.1007/s11060-016-2157-2. Epub 2016 Jun 7. J Neurooncol. 2016. PMID: 27270908 Free PMC article.

8

Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients.

Cachia D, Elshafeey NA, Kamiya-Matsuoka C, Hatami M, Alfaro-Munoz KD, Mandel JJ, Colen R, DeGroot JF. Cachia D, et al. Among authors: mandel jj. J Neurooncol. 2017 Oct;135(1):75-81. doi: 10.1007/s11060-017-2550-5. Epub 2017 Jul 12. J Neurooncol. 2017. PMID: 28702781

9

Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma.

Mandel JJ, Yust-Katz S, Patel AJ, Cachia D, Liu D, Park M, Yuan Y, Kent TA, de Groot JF. Mandel JJ, et al. Neuro Oncol. 2018 Jan 10;20(1):113-122. doi: 10.1093/neuonc/nox144. Neuro Oncol. 2018. PMID: 29016865 Free PMC article.

10

Neurologic complications of immune checkpoint inhibitors.

Fellner A, Makranz C, Lotem M, Bokstein F, Taliansky A, Rosenberg S, Blumenthal DT, Mandel J, Fichman S, Kogan E, Steiner I, Siegal T, Lossos A, Yust-Katz S. Fellner A, et al. J Neurooncol. 2018 May;137(3):601-609. doi: 10.1007/s11060-018-2752-5. Epub 2018 Jan 13. J Neurooncol. 2018. PMID: 29332184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters